Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label Efficacy, Safety, and Pharmacokinetic Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

NCT00667355 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00667355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label Efficacy, Safety, and Pharmacokinetic Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
January 31, 2011
Enrollment
41 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis